HIV/AIDS Co-Infection Therapy
Research from Johns Hopkins University provides new data about HIV/AIDS co-infection therapy
Published in AIDS Weekly, December 22nd, 2008
A new study, 'The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation,' is now available. According to a study from the United States, "The antiviral drug acyclovir is a guanosine nucleoside analog that potently inhibits herpes simplex virus (HSV) replication. Acyclovir treatment in patients coinfected with HSV and human immunodeficiency virus (HIV) has been observed to alter disease course and decrease HIV viral load, a finding that has been attributed to indirect effects of HSV suppression on HIV replication."
"Based on this hypothesis, several clinical studies have recently investigated the use...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-12-22)
More Articles from AIDS Weekly
- Emory University
Blocking immune inhibitor improves response to HIV-like virus, prolongs survival in monkeys - Research
Extraordinary immune cells may hold the key to managing HIV - Hepatitis
Research from L.J. Brant and co-researchers in the area of hepatitis published - Hepatitis C Virus
New hepatitis C virus study findings reported from J.A. Pineda and co-authors - HIV/AIDS
Data from Erasmus University provide new insights into HIV/AIDS - HIV/AIDS
Data on HIV/AIDS published by N.M. Araujo and colleagues - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
